Starting at midnight tonight, specially licensed medical cannabis dispensaries will have the opportunity to engage in the retail sale of marijuana to adults.
This week, the House Appropriations Committee released its 2018 Commerce, Justice, Science (CJS) Appropriations bill, which determines the funding levels for numerous federal agencies, including the Department of Justice. Predictably, the bill does not include language — known as the Rohrabacher-Blumenauer amendment — limiting the Justice Department from taking action against state-sanctioned medical cannabis producers, retailers, or consumers.
Pain patients report successfully substituting cannabis for opioids and other analgesics, according to data published online today in the journal Cannabis and Cannabinoid Research. Among those who acknowledged having used opioid-based pain medication within the past six months, 97 percent agreed that they were able to decrease their opiate intake with cannabis.
Too often we hear of violence being perpetrated by officers of the state against our fellow citizens on the basis of similarly irrational claims. Philando Castile is the name we must speak today, but sadly there are countless others, particularly people of color, who have fallen victims to or as a result of this senseless marijuana prohibition.
The enactment of statewide laws regulating the adult use and sale of cannabis is not associated with subsequent changes in traffic fatality rates, according to an analysis of traffic safety data published today in the American Journal of Public Health.
Federal courts have recently rejected the actions of university and college administrators who sought to inflict suspicionless drug tests on students at a public college and to restrict the First Amendment rights of marijuana law reformers at a public university. Both decisions have important national implications.